SCHEMBL4766898

SCHEMBL4766898

CCN[C@@H](CO)C(=O)Nc1ccc(-c2cccc(OCc3ccccc3)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.50
NR1H4 Q96RI1 1/20 0.49
MRGPRX4 Q96LA9 2/20 0.49
HDAC4 P56524 1/20 0.48
DHODH Q02127 1/20 0.48
F10 P00742 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SMPD1 P17405 1/20 0.47
NR4A2 P43354 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14456427 0.84 LTA4H (0.60) LTA4HNR1H4MRGPRX4HDAC4F10
SCHEMBL4766907 0.77 S1PR1 (0.54) LTA4HNR1H4MRGPRX4HDAC4DHODH
SCHEMBL4981969 0.76 S1PR1 (0.60) LTA4HNR1H4MRGPRX4HDAC4DHODH
SCHEMBL4981985 0.76 S1PR1 (0.60) LTA4HNR1H4MRGPRX4HDAC4DHODH
SCHEMBL20570050 0.74 F10 (0.58) LTA4HNR1H4F10SMPD1
SCHEMBL20570047 0.74 F10 (0.58) LTA4HNR1H4F10SMPD1
SCHEMBL14457050 0.73 DHODH (0.55) DHODH
SCHEMBL3678773 0.73 MRGPRX4 (0.64) NR1H4MRGPRX4HDAC4RAB9ASMN1; SMN2
SCHEMBL27684201 0.72 MEN1 (0.53) NR1H4MRGPRX4HDAC4DHODHF10
SCHEMBL14456431 0.72 BCL2 (0.62) LTA4HHDAC4NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981837-A2 METHODS AND COMPOSITIONS FOR MODULATING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ACTIVITY Praecis Pharmaceuticals Incorporated (US) 2008-10-22 EP disclosed
WO-2007092190-A2 METHODS AND COMPOSITIONS FOR MODULATING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ACTIVITY PRAECIS PHARMACEUTICALS, INC. (US) 2007-08-16 WO disclosed